Combination therapy shows potential in TP53-mutated head and neck cancers

May 10, 2019
Yale Cancer Center researchers have identified a potential combination therapy that appears promising for patients with TP53-mutated head and neck…

Costs, lengths of stay after CAR T-cell therapy greater for younger patients

May 10, 2019
Two studies presented at this year’s Transplantation & Cellular Therapy Meetings provided new insights into treatment costs and hospital…
Molecular Oncology

Recent advances in pancreatic cancer: From screening protocols to precision medicine paradigms

HemOnc Today, May 10, 2019
Aatur D. Singhi, MD, PhD; Anirban Maitra, MBBS
Pancreatic ductal adenocarcinoma, or PDAC, is the third most common cause of cancer-related death in the United States, with a median 5-year survival…

Discovery of new leukemia subtypes may lead to targeted therapies, better outcomes

May 5, 2019
Researchers at St. Jude Children’s Research Hospital identified eight new subtypes of B-cell acute lymphoblastic leukemia, an advance that they…
Trend Watch

Medicare’s proposed CAR T reimbursement increase ‘woefully inadequate’

April 30, 2019
CMS has announced a proposed 15% increase in the amount it would reimburse hospitals for inpatient CAR T-cell therapy for Medicare patients. The…

Trial to assess novel therapeutic approach for kidney cancer

April 25, 2019
Researchers at Dana-Farber Cancer Institute are testing a new treatment strategy designed to improve outcomes for patients with kidney cancer at high…
Meeting NewsVideo

VIDEO: Novel combinations can capitalize on immunogenicity of head and neck cancer

April 24, 2019
NEW YORK — Nabil F. Saba, MD, FACP, professor of hematology/medical oncology and otolaryngology and director of the head and neck oncology…
Meeting NewsVideo

VIDEO: ‘Huge effort’ underway to identify biomarkers in urothelial cancer

April 22, 2019
NEW YORK — Petros Grivas, MD, PhD, medical oncologist and clinical director of the genitourinary cancers program at University of Washington…

‘We have to cure’ cancer, says CAR T pioneer Carl H. June, MD

April 18, 2019
Carl H. June , MD, is about to receive an award for his life’s work — it's not his first and it certainly won’t…

Phase 3 trial assesses intraoperative radiotherapy for glioblastoma

April 17, 2019
An international randomized phase 3 trial is underway to evaluate the efficacy of intraoperative radiotherapy for patients with glioblastoma…